Filtered By:
Drug: Medroxyprogesterone
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 487 results found since Jan 2013.
Awareness of the non-contraceptive benefits of reversible contraceptive methods in a cohort of Brazilian women: an exploratory study
CONCLUSIONS: We found low awareness regarding the associated lower risk of ovarian, endometrial and cervical cancer associated with the use of some contraceptives, evidencing the need to provide more information about the non-contraceptive benefits during training for health care providers.PMID:35377262 | DOI:10.1080/13625187.2022.2054983
Source: The European Journal of Contraception and Reproductive Health Care - April 4, 2022 Category: Reproduction Medicine Authors: Luis Bahamondes None Mar ía Y Makuch Source Type: research
Progestogen supplementation during superovulation leads to higher embryo viability and TGFB1 gene expression in sheep
In conclusion, supplementation with P4 during the first follicular wave of the estrous cycle improves embryo viability and alters the expression of the TGFB1 gene.PMID:35124431 | DOI:10.1016/j.anireprosci.2022.106938
Source: Animal Reproduction Science - February 6, 2022 Category: Zoology Authors: Augusto Ryonosuke Taira Ribrio Ivan Tavares Pereira Batista Juliana Dantas Rodrigues Santos Pedro Henrique Nicolau Pinto Mario Felipe Alvarez Balaro Caroline Gomes do Esp írito Santo Viviane Lopes Brair Joanna Maria Gon çalves Souza-Fabjan Rodolfo Unger Source Type: research
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study
CONCLUSIONS: EL and MT demonstrated clinically meaningful efficacy in recurrent EC patients. The higher PFS observed in chemo-naïve patients is worthy of confirmation in future studies.PMID:35063278 | DOI:10.1016/j.ygyno.2021.12.031
Source: Gynecologic Oncology - January 22, 2022 Category: Cancer & Oncology Authors: Brian M Slomovitz Virginia L Filiaci Joan L Walker Michael C Taub Karen A Finkelstein John W Moroney Aimee C Fleury Carolyn Y Muller Laura L Holman Larry J Copeland David S Miller Robert L Coleman Source Type: research
The use of progestin subdermal implants in the management of endometriosis-related pain symptoms and quality of life: a systematic review
CONCLUSION: Etonogestrel- and segesterone-releasing progestin subdermal implants appear to improve endometriosis-related pain symptoms and quality of life, and may provide an additional component in the management of endometriosis. However, this systematic review is limited by a small sample size and heterogeneity in the data. As such, larger prospective randomized trials are needed to guide further management.PROSPERO Registration: CRD42021225665.PMID:35048754 | DOI:10.1080/03007995.2022.2031144
Source: Current Medical Research and Opinion - January 20, 2022 Category: Research Authors: Kristin Ambacher Michael Secter Ari P Sanders Source Type: research
Assessment of automated off-line solid-phase extraction LC-MS/MS to monitor EPA priority endocrine disruptors in tap water, surface water, and wastewater
This study set out to evaluate the suitability of automated off-line solid-phase extraction (SPE) liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) for the determination of EPA-priority EDCs in environmental water matrixes (tap water, surface water, and wastewater influents and effluents). The target molecules included 14 steroid hormones (altrenogest, androstenedione, equilenin, equilin, α-estradiol, β-estradiol, estriol, estrone, ethinylestradiol, levonorgestrel, medroxyprogesterone, norethindrone, progesterone, testosterone) and BPA. Factors that may influence the analytical performance were assessed. This ...
Source: Talanta - January 18, 2022 Category: Chemistry Authors: Ken Goeury Sung Vo Duy Gabriel Munoz Mich èle Prévost S ébastien Sauvé Source Type: research
